Adiantum Pharmatech Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2004.
2004 New Delhi, Delhi, India Struck Off
Last Updated:
About Adiantum Pharmatech Private Limited

Adiantum Pharmatech Private Limited, a struck off private limited company, was established on 30 November 2004 in New Delhi, Delhi, India. Engaging in other hospital and medical care activities within the healthcare sector, it holds CIN: U24232DL2004PTC130923. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Surjeet Ray (Director), Shashi Dhiman (Additional Director). Past directors included Dharam Pal Singh Sehrawat, Kunal Kumar Dhiman, Shashi Dhiman. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at Wz-295, 2Nd Floor, Gali No 10, Lajwanti Garden, New Delhi, Delhi, 110046.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2004PTC130923

  • Registration Number

    130923

  • Incorporation Date

    30 November 2004

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 3 Months
  • Last Filing with ROC 31 Mar 2016
Company report

Adiantum Pharmatech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Adiantum Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Adiantum Pharmatech Private Limited?
Current Directors
Name Designation Appointment Date Status
Surjeet Ray Director 02 Dec 2004 Current
Shashi Dhiman Additional Director 31 Oct 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Apr 2012 Past
Pramod Abcsdd Director 23 Nov 2015 Past
Pramod Abcsdd Director 08 Nov 2014 Past
Pramod Abcsdd Director 14 Nov 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Adiantum Pharmatech.

Enhance accessibility to Adiantum Pharmatech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Adiantum Pharmatech revenue growth over time
Adiantum Pharmatech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Adiantum Pharmatech?

In 2016, Adiantum Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Adiantum Pharmatech?

Unlock and access historical data on people associated with Adiantum Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Adiantum Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adiantum Pharmatech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Adiantum Pharmatech
Recent Activity within the Organization
  • Annual General Meeting

    The activity Adiantum Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was completed.

  • Balance Sheet

    Adiantum Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Shashi Dhiman was appointed as a Additional Director was appointed as a Additional Director on 31 Oct 2015 & has been associated with this company since 10 years 4 months . was completed.

  • Director Appointment

    Progress on Surjeet Ray was appointed as a Director was appointed as a Director on 02 Dec 2004 & has been associated with this company since 21 years 3 months . was documented.

  • Company Incorporation

    Progress on Adiantum Pharmatech Private Limited was registered on 30 Nov 2004 with Roc Delhi & aged 21 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Adiantum Pharmatech Private Limited?

The CIN of Adiantum Pharmatech Private Limited is U24232DL2004PTC130923.

Where is Adiantum Pharmatech Private Limited headquartered?

Adiantum Pharmatech Private Limited is headquartered at Wz-295, 2Nd Floor, Gali No 10, Lajwanti Garden, New Delhi, Delhi, 110046.

When was Adiantum Pharmatech Private Limited incorporated?

Adiantum Pharmatech Private Limited was incorporated on 30 November 2004.

Who are the current directors of Adiantum Pharmatech Private Limited?

The current directors of Adiantum Pharmatech Private Limited are

What is the primary industry of Adiantum Pharmatech Private Limited?

The primary industry of Adiantum Pharmatech Private Limited is Healthcare.

Is Adiantum Pharmatech Private Limited a listed company?

Adiantum Pharmatech Private Limited is unlisted.

What is the capital structure of Adiantum Pharmatech Private Limited?

The authorized capital of Adiantum Pharmatech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available